Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2005-08-10
Original market date: See footnote 1
2001-08-02
Product name:
HALOPERIDOL LONG ACTING
DIN:
02242631 Electronic product monograph is not available
Company:
NOVOPHARM LIMITED
30 Novopharm Court
Toronto
Ontario
Canada
M1B 2K9
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Intramuscular
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
28:16.08.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
N05AD01 HALOPERIDOL
Active ingredient group (AIG) number:See footnote5
0101774008
Active ingredient(s) See footnote8 | Strength |
---|---|
HALOPERIDOL (HALOPERIDOL DECANOATE) | 100 MG / ML |